The Houston compounding firm is pulling its tirzepatide and niacinamide injection because sterility couldn't be assured, and the vials had shipped nationwide.
Recap by typeshit. Full story at Morning Overview on MSN.
A Cleveland station segment touches on injectable peptides in a health roundup that also covers formula changes and keeping kids safe from lead.
Dr. Gagovic says slowed stomach emptying on Ozempic can leave food behind even after fasting, which he says raises aspiration risk under sedation.
The surgeon says two people who drop the same 80 pounds on a GLP-1 can end up with very different skin, and points to age as the reason.
The channel names nausea, vomiting, diarrhea, constipation, bloating and stomach pain as the most common GLP-1 side effects, and says that's why doses start low.
Symphony Health data reported by Bloomberg shows Novo Nordisk's oral Wegovy climbing again in week 42, up from 208,304 the week before.
Peltan argues validation, not discovery, limits drug timelines, citing retatrutide's path from 2019 trials to a planned 2027 filing as counterfeit versions already circulate.
Loading…